QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing

by Ysios Capital

QIAGEN N.V. has announced it has entered into an agreement to acquire STAT-Dx, a privately-held company developing the next generation of multiplex diagnostics for one-step, fully integrated molecular...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Regenera Levante partners with Magnum Ca...

by Magnum Capital Partners

Over little more than a decade, Regenera has built a strong track reco...

Photos Stream